biotech

HYDERABAD: Bharat BiotechInternational Limited (BBIL) said on Monday it has submitted phase III clinical trial data for its intranasal Covid-19 vaccine BBV154 to the Indian regulatory authorities. The submission was made after the…

Bharat Biotech on Monday said that it has submitted data for approval of its intranasal vaccine to the drug regulator. The intranasal vaccine been tested as both a preliminary dose and a mix-and-match booster on licensed Covid vaccines,…

HYDERABAD: Bharat Biotech International Limited(BBIL) on Monday said its intranasal Covid-19 vaccine BBV154 has proved to be safe, well-tolerated, and immunogenic in subjects in controlled clinical trials for the vaccine as a primary…

They added the chemical that triggered the first gene (corresponding to barcode A) for 24 hours, followed by the one for the second gene (corresponding to barcode B) for the next 24. “In theory we should have all the recording proteins…

After their transplants, the researchers followed the volunteers for two years. They concluded that the implants were safe to use and restored the thickness and curvature of the recipients’ natural corneas. Before the operation, 14 of…

When a patient goes into a clinic for an ultrasound of their stomach, they lie down on crinkly paper atop an exam table. A clinician spreads a thick goo on their abdomen, then presses a small probe into it to send acoustic waves into the…

SynopsisThe Biotechnology Regulatory Authority of India Bill has been pending in the Lok Sabha since 2013. Making it into law will pave the way for the development and use of high-yield, nutritionally enriched, and stress-resistant crop…